Serum albumin: a potential biomarker for liver involvement in SARS-CoV-2 infection

Serum albumin: a potential biomarker for liver involvement in SARS-CoV-2 infection

Saved in:

Bibliographic Details
Main Authors:	Neha Gupta, Bishuang Cai
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S235239642500009X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
by: Radi Taha Alsafi
Published: (2022-01-01)

Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity
by: Hanadi Abdullah Alwafi, et al.
Published: (2022-01-01)

Gastrointestinal System Involvement in Pediatric Patients with Acute SARS-CoV-2 Infection
by: Ozlem KALAYCIK SENGUL, et al.
Published: (2022-12-01)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
by: Cucunawangsih Cucunawangsih, et al.
Published: (2021-01-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection
by: Maria Alfreda Stincarelli, et al.
Published: (2025-01-01)

Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01)

Myocardial Damage in SARS-CoV-2 Infection
by: Elizabeth Sellén Sanchén, et al.
Published: (2020-11-01)

Metabolomic Profiling Reveals Potential Biomarkers and Prominent Features in HIV/AIDS Patients Co-Infected with SARS-CoV-2
by: Xuan Yan, et al.
Published: (2025-01-01)

Clozapine Serum Concentrations Are Disrupted by SARS-CoV-2 Vaccinations
by: Xenia A. K. Kersting, et al.
Published: (2023-01-01)

Human infection studies and the SARS-CoV-2 pandemic
by: Jörg Tremmel
Published: (2022-04-01)

Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
by: Byung Uk Lee
Published: (2021-12-01)

Cerebral Sinus Thrombosis Secondary to SARS-CoV-2 Infection
by: Mojtaba Khazaei, et al.
Published: (2021-01-01)

Clinicopathological Features of Cutaneous Findings of SARS-CoV-2 Infection
by: Bengu COBANOGLU, et al.
Published: (2022-09-01)

SARS-CoV-2 Infection in Cancer Patients: Essential Aspects
by: Juan Santiago Serna Trejos, et al.
Published: (2023-01-01)

Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19
by: Omar Ramos-Lopez, et al.
Published: (2020-01-01)

Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
by: Keneth Iceland, Kasozi, et al.
Published: (2021)

Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection
by: Nana Owusu-Boaitey
Published: (2025-02-01)

Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection
by: Elysse S. Tom, et al.
Published: (2021-01-01)

Male infertility along with the era of coronavirus infection SARS-CoV-2
by: N. G. Kulchenko, et al.
Published: (2022-12-01)

Recent advances in nutritional metabolism studies on SARS-CoV-2 infection
by: Yufen Jiang, et al.
Published: (2025-03-01)

Host factor PLAC8 is required for pancreas infection by SARS-CoV-2
by: Lesly Ibargüen-González, et al.
Published: (2025-02-01)

Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)

Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review
by: Yun Zhao, et al.
Published: (2025-02-01)

Clinical Evaluation of Acute Pancreatitis Caused by SARS-CoV-2 Virus Infection
by: Hulya Vatansev, et al.
Published: (2021-01-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
by: Jianhui Yang, et al.
Published: (2025-01-01)

SARS-CoV-2: Molecular Structure, Pathogenesis, Potential Therapeutic Targets, and Immune Response of the Infected Subject
by: R. Wumba, et al.
Published: (2022-01-01)

Gross Hematuria following SARS-CoV-2 Vaccination
by: Maryam Sattari, et al.
Published: (2023-01-01)

SARS-CoV-2 drug resistance and therapeutic approaches
by: Sania Batool, et al.
Published: (2025-01-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)

Ebola Virus and SARS-CoV-2: Similarities and Differences
by: Robert C. SIZEMORE, et al.
Published: (2020-07-01)

A systematic review of neurological symptoms and brain abnormalities in SARS-CoV-2 infections
by: Daniel Montoya, et al.
Published: (2023-08-01)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Keneth Iceland, Kasozi
Published: (2021)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023)

Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
by: Hiam Naiditch, et al.
Published: (2025-02-01)

Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
by: Wei Dai, et al.
Published: (2020-01-01)

Systematic Screening for SARS-CoV-2 to Detect Asymptomatic Infections: An Epitome of Taiwan’s Outbreak
by: Chih-Chien Cheng, et al.
Published: (2022-01-01)

Clinical characteristics of pediatric patients with SARS-CoV-2 infection. Cienfuegos, 2020-2021
by: Mercedes Fonseca Hernández, et al.
Published: (2022-03-01)

Seroprevalence of SARS-CoV-2 Infection Among People Living with HIV in Libreville, Gabon
by: Samira Zoa-Assoumou, et al.
Published: (2024-12-01)